Table 3.
Long-term outcomes
| RMN N = 10 |
MAN N = 12 |
Total N = 22 |
P-value | |
|---|---|---|---|---|
| PVC reduction > 90%* | 5/5 (100%) | 5/10 (56%) | 10/14 (71%) | 0.08 |
| VA Recurrence | 2 (20%) | 8 (67%) | 10 (46%) | 0.029 |
| Time to Recurrence (months) | 0 (0–0) | 2 (1–9) | 2 (0–8) | 0.38 |
| Redo procedure | 2 (20%) | 7 (58%) | 9 (41%) | 0.07 |
| Redo procedure number | 1 (1–1) | 1 (1–2) | 1 (1–1) | 0.08 |
MAN manual-guided radiofrequency ablation, PVC premature ventricular complex, RMN remote magnetic navigation-guided radiofrequency ablation, VA ventricular arrhythmia, VT ventricular tachycardia
*If PVC were present pre-procedural